Výsledky vyhledávání

Hepatologists’ awareness and knowledge toward NAFLD and the familiarity with renaming from NAFLD to MAFLD

Autor: Shereen Abdel, Alem, Yasser, Fouad, Mohamed, AbdAllah, Dina, Attia, Inas, Kamal, Ebada, Said, Ahmed, Gomaa, Sherief M, Abd-Elsalam, Yasmine, Gaber

Publikováno v: Endocrine, Metabolic & Immune Disorders - Drug Targets. 23

Background & Aims: Non-alcoholic fatty liver disease (NAFLD) is an emerging epidemic; it is a negative diagnosis that depends mainly on the presence of hepatic steatosis with or without inflammation after exclusion of other chronic liver diseases and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cfb01e6a2620336102fef31a6d1d392
https://doi.org/10.2174/1871530323666221028154159

Zobrazit plný text záznamu

Ramadan fasting and liver diseases: A review with practice advices and recommendations

Autor: Shamardan Ezzeldin S. Bazeed, Tarik I Zaher, Mohamed El-Nadry, Hanan Soliman, Ebada Said, Salem Y Mohamed, Hassan Elbatae, Asem Elfert, Ahmed Abdel-Razik, Sherief Abd-Elsalam, Mohamed H Emara

Publikováno v: Liver International. 41:436-448

Ramadan fasting is obligatory for Muslim healthy adults. However, there are many exemptions from fasting; including patients, whose diseases will be aggravated by fasting. Muslim patients with different liver diseases are frequently seen in the clini

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f136f964b11cd29573b88f6d69b0b3de
https://doi.org/10.1111/liv.14775

Zobrazit plný text záznamu

Plný text ve formátu HTML

The NAFLD‐MAFLD debate: Eminence vs evidence

Autor: Ebada Said, Dina Attia, Shamardan Ezzeldin S. Bazeed, Medhat Elsahhar, Yasser Fouad, Ahmed A. Gomaa, Enas M Kamal, Reda Elwakil, Almoutaz Hashim, Mai Mehrez

Publikováno v: Liver International. 41:255-260

Debates are inevitable in science and could be a powerful tool for addressing controversial topics as it promotes critical thinking and inspires individuals to consider alternate viewpoints. However, debates can help only to identify the issues that

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70047496fa7a300dd1a2f5c5f0588061
https://doi.org/10.1111/liv.14739

Zobrazit plný text záznamu

Hepatitis C Virus: Efficacy of New DAAs Regimens

Autor: Seham M. Mahmoud, Sherief Abd-Elsalam, Hala H. El Deeb, Ebada Said, Wahid Doss, Hassan Salama Shalby, Hoda Mohamed Rabie Gabal, Hadeel M. El-Hanafi, Amal Ahmed Mohamed, Naglaa El-Toukhy, Mahmoud Elkadeem, Hossameldin AbdelAziz

Publikováno v: Infectious Disorders - Drug Targets. 20:143-149

Background: HCV treatment showed dramatical change due to the introduction of potent, strong, direct antiviral drugs. Before the appearance of Direct-acting antivirals, multiple therapeutic interventions were used for hepatitis C, but none of these i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cfdd6b3325902ddb33ea401fb9b3aff
https://doi.org/10.2174/1871526519666190121114003

Zobrazit plný text záznamu

High success rates for the use of sofosbuvir/ombitasvir/paritaprevir/ritonavir + ribavirin and sofosbuvir/simeprevir/daclatasvir + ribavirin in retreatment of chronic hepatitis C infection after unsuccessful sofosbuvir/daclatasvir therapy: a real-life experience

Autor: Mohamed El Kassas, Mohammed Emadeldeen, Badawy A. Abdulaziz, Ebada Said, Ibrahim Hussein El Attar, Sherief Abd-Elsalam

Publikováno v: Archives of Virology. 165:1633-1639

The aim of this work was assessment of the efficacy and tolerability of two different regimens for retreatment of hepatitis C virus (HCV) patients who failed to respond to SOF/DCV-based therapy. This prospective study included 104 HCV patients who fa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::202f65e87bdf605d6adb2f80db3d848a
https://doi.org/10.1007/s00705-020-04639-x

Zobrazit plný text záznamu

Interleukin-18 and its gene single nucleotide polymorphisms (SNPs) influence chronic hepatitis C progression

Autor: Ebada Said, Rania Zakaria Aamer, Hend Ibrahim Shousha, Abeer A. Abo El-Azm, Mohamed Soliman, Mai Hamed Kamel, Mohamed Sanad Rashed, Fatma Mohamed Abd-Elsalam

Publikováno v: The Journal of Infection in Developing Countries. 12:257-264

Introduction: Interleukin-18 (IL-18) is a pro-inflammatory cytokine that is induced by hepatitis C virus (HCV) infection. Inter-individual variations of IL-18 gene expression may alter HCV-associated liver injury. Variable single nucleotide polymorph

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b438d6dda7e3a740e905f749951dc93a
https://doi.org/10.3855/jidc.9813

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání